Form 4 for GEHC GE HealthCare
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0000899243-23-001113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-05 | 2023-01-03 | GEHC | Makela Jan | CEO, Imaging | A - Grant | — | +32 | 32 | New | — |
| DM | 2023-01-05 | 2023-01-04 | GEHC | Makela Jan | CEO, Imaging | A - Grant | — | +235.9K | 28.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.01 per share | 2023-01-03 | A | A | 32 | — | 32 | D | — | — | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 66,191 | — | 66,191 | D | $76.37 · — to 2031-07-01 | 66,191 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F4) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will become exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024. |
| 3 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 3,243 | — | 3,243 | D | — · — to — | 3,243 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F6) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. |
| 4 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 19,555 | — | 19,555 | D | — · — to — | 19,555 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F7) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. |
| 5 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 14,846 | — | 14,846 | D | — · — to — | 14,846 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F8) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. |
| 6 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 8,209 | — | 8,209 | D | — · — to — | 8,209 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F9) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on July 1, 2023 and 50% will vest on July 1, 2024. |
| 7 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 14,569 | — | 14,569 | D | — · — to — | 14,569 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F5) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F10) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 1,469 | — | 1,469 | D | $129.52 · — to 2023-09-13 | 1,469 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 206 | — | 206 | D | $142.15 · — to 2024-09-05 | 206 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 2,328 | — | 2,328 | D | $142.15 · — to 2024-09-05 | 2,328 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 11 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 4,408 | — | 4,408 | D | $135.92 · — to 2025-09-11 | 4,408 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 12 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 7,345 | — | 7,345 | D | $161.30 · — to 2026-09-30 | 7,345 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 13 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 54,701 | — | 54,701 | D | $40.40 · — to 2028-12-21 | 54,701 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 14 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 5,967 | — | 5,967 | D | $57.74 · — to 2029-03-19 | 5,967 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 15 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 4,037 | — | 4,037 | D | $51.67 · — to 2029-04-11 | 4,037 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 16 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 240 | — | 240 | D | $63.51 · — to 2030-03-02 | 240 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F3) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023. |
| 17 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 28,615 | — | 28,615 | D | $63.51 · — to 2030-03-02 | 28,615 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F3) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023. |